Long-Acting Reversible Contraceptives Good for Teens

Share this content:
Long-Acting Reversible Contraceptives Good for Teens
Long-Acting Reversible Contraceptives Good for Teens

FRIDAY, April 27, 2018 (HealthDay News) -- Long-acting reversible contraceptives (LARC) are suitable for use by adolescents, according to a Committee Opinion published in the May issue of Obstetrics & Gynecology.

Noting that from 2006 to 2010, 82 percent of adolescents at risk of unintended pregnancy were using contraception but only 59 percent used a highly-effective method, researchers from the American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care address contraception among adolescents.

The researchers note that, compared with short-acting contraceptives, LARC have higher efficacy, continuation rates, and satisfaction rates among adolescents who choose to use them. Complications associated with intrauterine devices and contraceptive implants are rare, with little difference between adolescents and women, indicating that these methods are safe for adolescents. Patients' lack of familiarity with or understanding of these methods, potentially high cost of initiation, lack of access, low parental acceptance, and obstetrician-gynecologists' and other health care providers' misconceptions about LARC safety in adolescents are barriers to LARC use. Obstetrician-gynecologists should continue to follow standard guidelines for sexually transmitted infection (STI) screening because of the increased risk among adolescents. Adolescents who use LARC should be encouraged to use male or female condoms to reduce the risk of STIs.

"Obstetrician-gynecologists should counsel all sexually active adolescents who do not seek pregnancy on the range of reversible contraceptive methods, including LARC, and should help make these contraceptives readily accessible to them," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »